SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies

We summarize here in vitro evidences of efficacy for convalescent plasma, currently approved vaccines and monoclonal antibodies against SARS-CoV-2 variants of concern (VOC: B.1.1.7, B.1.351, P.1, and B.1.617.2), variants of interest (VOI: B.1.427/B.1.429, P.2, B.1.525, P.3, B.1.526, and B.1.671.1),...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Tuccori, Marco, Baj, Andreina, Maggi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310233/
https://www.ncbi.nlm.nih.gov/pubmed/34201767
http://dx.doi.org/10.3390/v13071211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310233/
https://www.ncbi.nlm.nih.gov/pubmed/34201767
http://dx.doi.org/10.3390/v13071211

Ejemplares similares